Leap Therapeutics (NASDAQ: LPTX)
$3.29
(2.8%)
$0.09
Price as of April 24, 2024, 4:00 p.m. ET
Leap Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Leap Therapeutics Company Info
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
News & Analysis
Featured Article
Why Leap Therapeutics Stock Is Surging Today
Positive clinical trial results are giving investors a reason to cheer.
Cory Renauer | Jan 19, 2022
Featured Article
2 Risky Growth Stocks That Could Make You Filthy Rich
These two biotech stocks are set to report key clinical data later this year.
George Budwell | Jan 16, 2022
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.